The p66Shc Protein Mediates Insulin Resistance and Secretory Dysfunction in Pancreatic β-Cells Under Lipotoxic Conditions
- 1 August 2022
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 71 (8) , 1763-1771
Abstract
We evaluated the role of the p66Shc redox adaptor protein in pancreatic β-cell insulin resistance that develops under lipotoxic conditions and with excess body fat. Prolonged exposure to palmitate in vitro or the presence of overweight/obesity augmented p66Shc expression levels and caused an impaired ability of exogenous insulin to increase cellular insulin content and secreted C-peptide levels in INS-1E cells and human and murine islets. In INS-1E cells, p66Shc knockdown resulted in enhanced insulin-induced augmentation of insulin content and C-peptide secretion and prevented the ability of palmitate to impair these effects of insulin. Conversely, p66Shc overexpression impaired insulin-induced augmentation of insulin content and C-peptide secretion in both the absence and presence of palmitate. Under lipotoxic condition, the effects of p66Shc are mediated by a p53-induced increase in p66Shc protein levels and JNK-induced p66Shc phosphorylation at Ser36 and appear to involve the phosphorylation of the ribosomal protein S6 kinase at Thr389 and of insulin receptor substrate 1 at Ser307, resulting in the inhibition of insulin-stimulated protein kinase B phosphorylation at Ser473. Thus, the p66Shc protein mediates the impaired β-cell function and insulin resistance induced by saturated fatty acids and excess body fat.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and miceJournal of Hepatology, 2012
- Modulation of β‐cell function: a translational journey from the bench to the bedsideDiabetes, Obesity and Metabolism, 2012
- Autocrine regulation of insulin secretionDiabetes, Obesity and Metabolism, 2012
- Influence of Hyperinsulinemia and Insulin Resistance on In Vivo β-Cell FunctionDiabetes, 2011
- Mammalian life-span determinant p66 shcA mediates obesity-induced insulin resistanceProceedings of the National Academy of Sciences, 2010
- Regulation of glucose-dependent insulin secretion by insulin: Possible role of AMP-activated protein kinaseLife Sciences, 2009
- S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-α Signaling through IKK2Journal of Biological Chemistry, 2008
- Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substratesProceedings of the National Academy of Sciences, 2006
- Genetic Deletion of the p66 Shc Adaptor Protein Protects From Angiotensin II–Induced Myocardial DamageHypertension, 2005
- Alterations in growth and apoptosis of insulin receptor substrate-1-deficient β-cellsAmerican Journal of Physiology-Endocrinology and Metabolism, 2005